-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...

-The Economic Times NEW DELHI: Basmati rice exports to the US have plunged because many Indian firms are under an import alert by the US authorities, leading to a detailed scrutiny for pesticide residue in every grain being shipped out. This has raised costs, upset schedules and obstructed sales, prompting exporters to seek government intervention. In the first quarter of calendar year 2013, exports were down to 19,583 tonne. With 31 Indian...

-The Business Standard Data also show that several other leading domestic pharma companies have recalled their products from the US Frequent drug recalls, warning letters and import alerts from the US in the recent past have turned into a major concern for the Indian pharmaceutical industry and investors. While Ranbaxy Laboratories recently pleaded guilty before the US authorities for its wrongdoings in the past, the crackdown on the drug companies seems to...

-Newsclick.in A few weeks back Fortune magazine and CNN carried a long online blog titled ‘Dirty Medicine' by Dinesh Thakur, a former employ of Ranbaxy, where he recounts how he came across several procedural and other lapses in the company's manufacturing facilities. Since then the Fortune blog has become one of the most widely circulated and commented upon business stories in the world. The story received attention as it came in the...

-The Economic Times MUMBAI: The United States Food and Drug Administration (USFDA), widely considered the world's most stringent regulatory authority, has said India's share in generic exports to the US over the years is an indication of the good manufacturing norms practised by Indian drugmakers. As the Ranbaxy scandal threatens to tarnish India's image as a hub of manufacturing world-class generic drugs, the statement, by USFDA's spokesman Chris Kelly in an...